Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04513951
Title AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients (AVETRIC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Gruppo Oncologico del Nord-Ovest
Indications

colorectal adenocarcinoma

colorectal cancer

Therapies

Avelumab + Cetuximab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Age Groups: senior | adult
Covered Countries ITA

Additional content available in CKB BOOST